CHE

Chemed Corporation (CHE)

Last Price$550.6(0.9%)
Market Cap$8,290.2M
LTM Operating Income
$364.0M
YoY Growth
+17.2%
3Y CAGR
-2.1%
5Y CAGR
+8.0%
Stock quality & Intrinsic value
7/10
30.1% overvalued

Chemed Corporation Operating Income

Annual
Quarterly
LTM
Crunching data... Almost there!
Dec'04Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
Operating Income
$58.1M
$79.4M
$105.0M
$122.8M
$132.9M
$126.3M
$143.5M
$153.7M
$156.4M
$133.4M
$168.4M
$184.5M
$178.7M
$113.0M
$243.6M
$257.4M
$389.7M
$343.0M
$343.5M
$340.6M
CHE
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for CHE and see if it's the right time to invest.
Dive in

Chemed Corporation (CHE) Operating Income comparison analysis

Crunching data... Almost there!

CHE key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!

Discover more Stock Ideas

FAQ

1) What is Chemed Corporation's Operating Income?

As of today, Chemed Corporation's last 12-month Operating Income is $364.0M, based on the financial report for Sep 30, 2024 (Q3 2024).

2) What is Chemed Corporation's Operating Income growth rate?

Over the last year, Chemed Corporation's Operating Income growth was 17.2%. The average annual Operating Income growth rates for Chemed Corporation have been (2.3%) over the past three years, 8.0% over the past five years.

3) Is Chemed Corporation's Operating Income growth rate Good?

Over the last year, Chemed Corporation's Operating Income growth was 17.2%, which is higher than industry growth of (0.0%). It indicates that Chemed Corporation's Operating Income growth is Good.

4) How does Chemed Corporation's Operating Income growth rate compare to its peers?

Over the last year, Chemed Corporation's Operating Income growth was 17.2%, which is lower than peer median growth of 17.8%. The list of peers includes HCA, THC, DVA, FMS, UHS, EHC, ACHC, ENSG, OPCH, AMED etc.